Literature DB >> 9690413

Increased aspartate aminotransferase activity in cerebrospinal fluid and Alzheimer's disease.

T Tapiola, M Lehtovirta, T Pirttilä, I Alafuzoff, P Riekkinen, H Soininen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9690413     DOI： 10.1016/S0140-6736(05)60260-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

1.  Family history and TOMM40 '523 interactive associations with memory in middle-aged and Alzheimer's disease cohorts.

Authors:  Auriel A Willette; Joseph L Webb; Michael W Lutz; Barbara B Bendlin; Alexandra M Wennberg; Jennifer M Oh; Allen Roses; Rebecca L Koscik; Bruce P Hermann; N Maritza Dowling; Sanjay Asthana; Sterling C Johnson
Journal:  Alzheimers Dement       Date:  2017-05-23       Impact factor: 21.566

2.  Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease.

Authors:  Richard J Perrin; Rebecca Craig-Schapiro; James P Malone; Aarti R Shah; Petra Gilmore; Alan E Davis; Catherine M Roe; Elaine R Peskind; Ge Li; Douglas R Galasko; Christopher M Clark; Joseph F Quinn; Jeffrey A Kaye; John C Morris; David M Holtzman; R Reid Townsend; Anne M Fagan
Journal:  PLoS One       Date:  2011-01-12       Impact factor: 3.240

Review 3.  Kynurenines, neurodegeneration and Alzheimer's disease.

Authors:  Zsigmond Tamas Kincses; József Toldi; László Vécsei
Journal:  J Cell Mol Med       Date:  2010-07-12       Impact factor: 5.310
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.